Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Radiat Oncol. 2019 Jul 8;14(1):119. doi: 10.1186/s13014-019-1326-9.
Radiation therapy is a mainstay in the treatment of esophageal cancer (EC) patients, and photon radiotherapy has proved beneficial both in the neoadjuvant and the definitive setting. However, regarding the still poor prognosis of many EC patients, particle radiation employing a higher biological effectiveness may help to further improve patient outcomes. However, the influence of clinically available particle radiation on EC cells remains largely unknown.
Patient-derived esophageal adenocarcinoma and squamous cell cancer lines were treated with photon and particle irradiation using clinically available proton (H), carbon (C) or oxygen (O) beams at the Heidelberg Ion Therapy Center. Histology-dependent clonogenic survival was calculated for increasing physical radiation doses, and resulting relative biological effectiveness (RBE) was calculated for each radiation modality. Cell cycle effects caused by photon and particle radiation were assessed, and radiation-induced apoptosis was measured in adenocarcinoma and squamous cell EC samples by activated caspase-3 and sub-G1 populations. Repair kinetics of DNA double strand breaks induced by photon and particle radiation were investigated.
While both adenocarcinoma EC cell lines demonstrated increasing sensitivities for H, C and O radiation, the two squamous cell carcinoma lines exhibited a more heterogeneous response to photon and particle treatment; average RBE values were calculated as 1.15 for H, 2.3 for C and 2.5 for O irradiation. After particle irradiation, squamous cell EC samples reacted with an increased and prolonged block in G2 phase of the cell cycle compared to adenocarcinoma cells. Particle radiation resulted in an incomplete repair of radiation-induced DNA double strand breaks in both adenocarcinoma and squamous cell carcinoma samples, with the levels of initial strand break induction correlating well with the individual cellular survival after photon and particle radiation. Similarly, EC samples demonstrated heterogeneous levels of radiation-induced apoptosis that also corresponded to the observed cellular survival of individual cell lines.
Esophageal cancer cells exhibit differential responses to irradiation with photons and H, C and O particles that were independent of tumor histology. Therefore, yet unknown molecular markers beyond histology may help to establish which esophageal cancer patients benefit from the biological effects of particle treatment.
放射治疗是食管癌(EC)患者治疗的主要手段,光子放射治疗已被证明在新辅助和确定性治疗中均有益处。然而,对于许多 EC 患者仍然较差的预后,采用更高生物学效应的粒子辐射可能有助于进一步改善患者的结局。然而,临床上可用的粒子辐射对 EC 细胞的影响在很大程度上仍然未知。
使用海德堡离子治疗中心提供的临床可用质子(H)、碳(C)或氧(O)束对源自患者的食管腺癌和鳞状细胞癌系进行光子和粒子照射。针对增加的物理辐射剂量计算组织学依赖性克隆存活,并为每种辐射方式计算相对生物学效应(RBE)。评估光子和粒子辐射引起的细胞周期效应,并通过激活的 caspase-3 和亚 G1 群体测量腺癌和鳞状细胞 EC 样本中的辐射诱导凋亡。研究光子和粒子辐射诱导的 DNA 双链断裂的修复动力学。
尽管两种腺癌 EC 细胞系对 H、C 和 O 辐射的敏感性均增加,但两种鳞状细胞癌系对光子和粒子治疗的反应更为多样化;平均 RBE 值分别计算为 H 为 1.15、C 为 2.3 和 O 为 2.5 照射。与腺癌细胞相比,经粒子照射后,鳞状细胞 EC 样本中细胞周期 G2 期的阻滞增加且延长。在腺癌和鳞状细胞癌样本中,粒子辐射导致辐射诱导的 DNA 双链断裂的不完全修复,初始链断裂诱导水平与光子和粒子辐射后单个细胞的存活情况密切相关。同样,EC 样本显示出辐射诱导凋亡的异质性水平,这也与观察到的各个细胞系的细胞存活情况相对应。
食管癌细胞对光子和 H、C 和 O 粒子的照射表现出不同的反应,这种反应与肿瘤组织学无关。因此,除组织学以外的未知分子标志物可能有助于确定哪些食管癌患者受益于粒子治疗的生物学效应。